{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T07:26:35Z","timestamp":1794727595866,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T00:00:00Z","timestamp":1629072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Liver injuries have been reported in patients with coronavirus disease 2019 (COVID-19). This study aimed to investigate the clinical role played by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this multicentre, retrospective study, the parameters of liver function tests in COVID-19 inpatients were compared between various time-points in reference to SARS-CoV-2 shedding, and 3 to 7\u00a0days before the first detection of viral shedding was regarded as the reference baseline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total, 70 COVID-19 inpatients were enrolled. Twenty-two (31.4%) patients had a self-medication history after illness. At baseline, 10 (14.3%), 7 (10%), 9 (12.9%), 2 (2.9%), 15 (21.4%), and 4 (5.7%) patients already had abnormal alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), alkaline phosphatase (ALP), albumin, and total bilirubin (TBIL) values, respectively. ALT and AST abnormal rates and levels did not show any significant dynamic changes during the full period of viral shedding (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). The GGT abnormal rate (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008) and level (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.033) significantly increased on day 10 of viral shedding. Meanwhile, no simultaneous significant increases in abnormal ALP rates and levels were observed. TBIL abnormal rates and levels significantly increased on days 1 and 5 of viral shedding (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Albumin abnormal decrease rates increased, and levels decreased consistently from baseline to SARS-CoV-2 clearance day (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Thirteen (18.6%) patients had chronic liver disease, two of whom died. The ALT and AST abnormal rates and levels did not increase in patients with chronic liver disease during SARS-CoV-2 shedding.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SARS-CoV-2 does not directly lead to elevations in ALT and AST but may result in elevations in GGT and TBIL; albumin decreased extraordinarily even when SARS-CoV-2 shedding ended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-021-06572-z","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T05:04:23Z","timestamp":1629090263000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Dynamic changes in liver function parameters in patients with coronavirus disease 2019: a multicentre, retrospective study"],"prefix":"10.1186","volume":"21","author":[{"given":"Qing-Lei","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zu-Jiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanpu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Hai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Bao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Lin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,16]]},"reference":[{"key":"6572_CR1","unstructured":"World Health Organization. Weekly Operational Update on COVID-19. September 25, 2020. https:\/\/www.who.int\/publications\/m\/item\/weekly-update-on-covid-19---25-september. Accessed 15 Aug 2021."},{"issue":"10222","key":"6572_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0140-6736(20)30300-7","volume":"395","author":"FS Wang","year":"2020","unstructured":"Wang FS, Zhang C. What to do next to control the 2019-nCoV epidemic? Lancet. 2020;395(10222):391\u20133.","journal-title":"Lancet"},{"issue":"1","key":"6572_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/infdis\/jiaa228","volume":"222","author":"QL Zeng","year":"2020","unstructured":"Zeng QL, Yu ZJ, Gou JJ, Li GM, Ma SH, Zhang GF, et al. Effect of convalescent plasma therapy on viral shedding and survival in patients with coronavirus disease 2019. J Infect Dis. 2020;222(1):38\u201343.","journal-title":"J Infect Dis"},{"issue":"18","key":"6572_CR4","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320.","journal-title":"N Engl J Med"},{"issue":"11","key":"6572_CR5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan. China JAMA. 2020;323(11):1061\u20139.","journal-title":"China JAMA"},{"issue":"5","key":"6572_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S2468-1253(20)30057-1","volume":"5","author":"C Zhang","year":"2020","unstructured":"Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5(5):428\u201330.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"6572_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jhep.2020.06.006","volume":"73","author":"D Jothimani","year":"2020","unstructured":"Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J Hepatol. 2020;73(5):1231\u201340.","journal-title":"J Hepatol"},{"issue":"6","key":"6572_CR8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3390\/pathogens9060430","volume":"9","author":"K Morgan","year":"2020","unstructured":"Morgan K, Samuel K, Vandeputte M, Hayes PC, Plevris JN. SARS-CoV-2 Infection and the liver. Pathogens. 2020;9(6):430.","journal-title":"Pathogens"},{"key":"6572_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/2020.02.03.931766","author":"X Chai","year":"2020","unstructured":"Chai X, Hu L, Zhang Y, Han W, Lu Z, Ke A, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. Bio-Rxiv. 2020. https:\/\/doi.org\/10.1101\/2020.02.03.931766.","journal-title":"Bio-Rxiv"},{"issue":"6","key":"6572_CR10","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1111\/tbed.13674","volume":"67","author":"QL Zeng","year":"2020","unstructured":"Zeng QL, Li GM, Ji FP, Ma SH, Zhang GF, Xu JH, et al. Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: a multicentre, retrospective study. Transbound Emerg Dis. 2020;67(6):2971\u201382.","journal-title":"Transbound Emerg Dis"},{"key":"6572_CR11","unstructured":"World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. January 28, 2020. https:\/\/apps.who.int\/iris\/handle\/10665\/330893. Accessed 15 Aug 2021."},{"issue":"15","key":"6572_CR12","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1001\/jama.2020.2783","volume":"323","author":"L Lan","year":"2020","unstructured":"Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR test results in patients recovered from COVID-19. JAMA. 2020;323(15):1502\u20133.","journal-title":"JAMA"},{"key":"6572_CR13","unstructured":"National Health Commission of the People\u2019s Republic of China. Chinese management guideline for COVID-19 (version 6.0). February 18, 2020. http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202002\/8334a8326dd94d329df351d7da8aefc2\/files\/b218cfeb1bc54639af227f922bf6b817.pdf. Accessed 15 Aug 2021. (In Chinese)."},{"issue":"1","key":"6572_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1\u201398.","journal-title":"Hepatol Int."},{"issue":"5","key":"6572_CR15","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/liv.14435","volume":"40","author":"L Xu","year":"2020","unstructured":"Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40(5):998\u20131004.","journal-title":"Liver Int."},{"issue":"7798","key":"6572_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265\u20139.","journal-title":"Nature"},{"issue":"8","key":"6572_CR17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u201333.","journal-title":"N Engl J Med"},{"issue":"2","key":"6572_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/hep.20111","volume":"39","author":"TN Chau","year":"2004","unstructured":"Chau TN, Lee KC, Yao H, Tsang TY, Chow TC, Yeung YC, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology. 2004;39(2):302\u201310.","journal-title":"Hepatology"},{"issue":"5","key":"6572_CR19","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3201\/eid1005.030640","volume":"10","author":"JT Wang","year":"2004","unstructured":"Wang JT, Sheng WH, Fang CT, Chen YC, Wang JL, Yu CJ, et al. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004;10(5):818\u201324.","journal-title":"Emerg Infect Dis"},{"issue":"10223","key":"6572_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313.","journal-title":"Lancet"},{"issue":"10223","key":"6572_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395(10223):497\u2013506.","journal-title":"China Lancet"},{"key":"6572_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1136\/bmj.m606","volume":"368","author":"XW Xu","year":"2020","unstructured":"Xu XW, Wu XX, Jiang XG, Xu KJ, Ying LJ, Ma CL, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:606.","journal-title":"BMJ."},{"issue":"1","key":"6572_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","volume":"24","author":"Y Cheng","year":"2005","unstructured":"Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, et al. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005;24(1):44\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9371","key":"6572_CR24","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","volume":"361","author":"JS Peiris","year":"2003","unstructured":"Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361(9371):1767\u201372.","journal-title":"Lancet"},{"issue":"1","key":"6572_CR25","doi-asserted-by":"publisher","first-page":"E207","DOI":"10.1148\/radiol.2020201908","volume":"297","author":"R Bhayana","year":"2020","unstructured":"Bhayana R, Som A, Li MD, et al. Abdominal imaging findings in COVID-19: preliminary observations. Radiology. 2020;297(1):E207\u201315.","journal-title":"Radiology"},{"issue":"3","key":"6572_CR26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.jhep.2020.04.006","volume":"73","author":"Q Cai","year":"2020","unstructured":"Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19: Abnormal liver function tests. J Hepatol. 2020;73(3):566\u201374.","journal-title":"J Hepatol."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06572-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06572-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06572-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T05:07:30Z","timestamp":1629090450000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06572-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6572"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06572-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-48131\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,16]]},"assertion":[{"value":"15 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Commissions of The First Affiliated Hospital of Zhengzhou University and each involved centers, all these institutions approved to access the raw data mentioned in the methods, the raw data did not contain any personal identifying information that can be linked to particular individuals, and was anonymised before its use. The requirement for informed consent was waived by the Institutional Review Commissions in light of de-identified data of patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no financial or non-financial interests with other people or organizations that could inappropriately influence this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"818"}}